Cargando…
Metabolic phenotype in Darier disease: a cross-sectional clinical study
BACKGROUND: Human data supporting a role for endoplasmic reticulum (ER) stress and calcium dyshomeostasis in diabetes is scarce. Darier disease (DD) is a hereditary skin disease caused by mutations in the ATP2A2 gene encoding the sarcoendoplasmic-reticulum ATPase 2 (SERCA2) calcium pump, which cause...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003329/ https://www.ncbi.nlm.nih.gov/pubmed/32042314 http://dx.doi.org/10.1186/s13098-020-0520-0 |
_version_ | 1783494510743912448 |
---|---|
author | Ahanian, Tara Curman, Philip Leong, Ivone U. S. Brismar, Kerstin Bachar-Wikstrom, Etty Cederlöf, Martin Wikstrom, Jakob D. |
author_facet | Ahanian, Tara Curman, Philip Leong, Ivone U. S. Brismar, Kerstin Bachar-Wikstrom, Etty Cederlöf, Martin Wikstrom, Jakob D. |
author_sort | Ahanian, Tara |
collection | PubMed |
description | BACKGROUND: Human data supporting a role for endoplasmic reticulum (ER) stress and calcium dyshomeostasis in diabetes is scarce. Darier disease (DD) is a hereditary skin disease caused by mutations in the ATP2A2 gene encoding the sarcoendoplasmic-reticulum ATPase 2 (SERCA2) calcium pump, which causes calcium dyshomeostasis and ER stress. We hypothesize that DD patients have a diabetes-like metabolic phenotype and the objective of this study was to examine the association between DD with impaired glucose tolerance and diabetes. METHODS: Cross-sectional clinical study on 25 DD patients and 25 matched controls. Metabolic status was assessed primarily by fasting blood glucose, oral glucose tolerance test, HOMA2-%S (insulin resistence) and HOMA2-%B (beta cell function). RESULTS: DD subjects showed normal oral glucose tolerance test and HOMA2-%S, while fasting blood glucose was lower and c-peptide as well as HOMA2-%B was higher. CONCLUSION: Increased HOMA2-%B values are indicative of increased basal insulin secretion which is a type of beta cell dysfunction associated to diabetes development. These results supports a role of ER stress in diabetes pathophysiology and contribute to the understanding of DD as a multi-organ syndrome. |
format | Online Article Text |
id | pubmed-7003329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70033292020-02-10 Metabolic phenotype in Darier disease: a cross-sectional clinical study Ahanian, Tara Curman, Philip Leong, Ivone U. S. Brismar, Kerstin Bachar-Wikstrom, Etty Cederlöf, Martin Wikstrom, Jakob D. Diabetol Metab Syndr Research BACKGROUND: Human data supporting a role for endoplasmic reticulum (ER) stress and calcium dyshomeostasis in diabetes is scarce. Darier disease (DD) is a hereditary skin disease caused by mutations in the ATP2A2 gene encoding the sarcoendoplasmic-reticulum ATPase 2 (SERCA2) calcium pump, which causes calcium dyshomeostasis and ER stress. We hypothesize that DD patients have a diabetes-like metabolic phenotype and the objective of this study was to examine the association between DD with impaired glucose tolerance and diabetes. METHODS: Cross-sectional clinical study on 25 DD patients and 25 matched controls. Metabolic status was assessed primarily by fasting blood glucose, oral glucose tolerance test, HOMA2-%S (insulin resistence) and HOMA2-%B (beta cell function). RESULTS: DD subjects showed normal oral glucose tolerance test and HOMA2-%S, while fasting blood glucose was lower and c-peptide as well as HOMA2-%B was higher. CONCLUSION: Increased HOMA2-%B values are indicative of increased basal insulin secretion which is a type of beta cell dysfunction associated to diabetes development. These results supports a role of ER stress in diabetes pathophysiology and contribute to the understanding of DD as a multi-organ syndrome. BioMed Central 2020-02-05 /pmc/articles/PMC7003329/ /pubmed/32042314 http://dx.doi.org/10.1186/s13098-020-0520-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ahanian, Tara Curman, Philip Leong, Ivone U. S. Brismar, Kerstin Bachar-Wikstrom, Etty Cederlöf, Martin Wikstrom, Jakob D. Metabolic phenotype in Darier disease: a cross-sectional clinical study |
title | Metabolic phenotype in Darier disease: a cross-sectional clinical study |
title_full | Metabolic phenotype in Darier disease: a cross-sectional clinical study |
title_fullStr | Metabolic phenotype in Darier disease: a cross-sectional clinical study |
title_full_unstemmed | Metabolic phenotype in Darier disease: a cross-sectional clinical study |
title_short | Metabolic phenotype in Darier disease: a cross-sectional clinical study |
title_sort | metabolic phenotype in darier disease: a cross-sectional clinical study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003329/ https://www.ncbi.nlm.nih.gov/pubmed/32042314 http://dx.doi.org/10.1186/s13098-020-0520-0 |
work_keys_str_mv | AT ahaniantara metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy AT curmanphilip metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy AT leongivoneus metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy AT brismarkerstin metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy AT bacharwikstrometty metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy AT cederlofmartin metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy AT wikstromjakobd metabolicphenotypeindarierdiseaseacrosssectionalclinicalstudy |